You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report- Hagens Berman
- 2. wO Börsenlounge - die Woche: Von Quanten-Aktien, der Commerzbank-Übernahme und einem Porsche Short-Squeeze
- 3. Just one exercise session could help fight cancer, research finds
- 4. Synergistic strategies in photodynamic combination therapy for cancer: mechanisms, nanotechnology, and clinical translation
- 5. Exploration of the clinical prognostic model of BRCA based on PCAT7
- 6. Case Report: Personalized treatment in stage IV breast cancer using the patient-derived organoids
- 7. ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
- 8. ARTBIO Lands $132M Series B Financing
- 9. Bioinformatics-based prognostic value and in vitro functional validation of PTK6 in cutaneous melanoma
- 10. Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy
Last updated at 5:19 GMT
Hot News Makers
Health/Pharma Companies
-
60245.81
-
58395.47
-
57264.57
-
37118.08
-
23400.45
-
21702.78
-
10573.70
-
9264.74
-
8865.14
-
5604.20
Drugs, Treatments, Trials
-
13614.58
-
8775.35
-
7722.31
-
7440.45
-
7150.29
-
6027.64
-
5177.93
-
4350.45
-
4216.26
-
4080.25
Last updated at 5:10 GMT
